1. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney International Supplements. 2021;11(2):1-274.
[2]
2. Alpers CE, Chang A. The Kidney. In: Kumar V, Abbas AK, Aster JC, editors. Robbins and Cotran Pathologic Basis of Disease. 10th ed. Philadelphia: Elsevier; 2021.
[3]
3. Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis: Pathogenetic heterogeneity and proposal of a new classification. Semin Nephrol. 2021;41(4):309-320.
[4]
4. Masani N, Jhaveri KD, Fishbane S. Update on membranoproliferative GN. Clin J Am Soc Nephrol. 2020;15(12):1813-1824.
[5]
5. World Health Organization. ICD-10: International Statistical Classification of Diseases and Related Health Problems. 10th Revision. Geneva: WHO; 2019.
[6]
6. Johnson RJ, Feehally J, Floege J. Comprehensive Clinical Nephrology. 6th ed. Philadelphia: Elsevier; 2022.
[7]
7. Bomback AS, Appel GB. Updates on the diagnosis and management of membranoproliferative glomerulonephritis. Kidney Int. 2022;101(3):478-492.
[8]
8. Smith RJH, Harris CL, Pickering MC. Dense deposit disease. Clin J Am Soc Nephrol. 2021;16(12):1857-1870.